FOXF2 and bone metastasis: The patients were divided into high FOXF2 mRNA level (FOXF2high) and low FOXF2 mRNA level (FOXF2low) groups, using the optimal cutoff value of FOXF2 mRNA expression for distinguishing bone metastasis-free survival (BMFS) statuses in overall cases and cases stratified by subtypes.